A Monkey Herpesvirus Could Hold Key to New Cancer Treatment

Herpes cousin can simply fight cancer. Scientists, a protein caused by a herpesvirus, monkeys, a protein that could increase the potential of the immune system against cancer.

Researchers at Michigan University explain their work on protein on a piece of paper published last month. In experiments with mice, protein extended the life of the T-cells fighting cancer, caused the reduced tumor growth. The findings point to a novel way we can further strengthen immune cancer treatment.

Protein comes Herpesvirus symerinamed after squirrel monkeys (members of all breeds) Seyumani) The virus infects primarily. Researchers activated certain roads in the virus T cells, proteins identified the frontal troops against infections and cancer and prevented the monster. As a result, the virus called Torosin Kinase mutual protein (end) has developed a special protein-changed version. In the Type-cells of the Type T cells, they hoped that in cells in stimulating the production of cells and cancer killing potential in a protein.

As expected, the protein increased the level of stat (Special protein stat5) in a petri dish. Then they tested the protein to mice with melanoma and lymphoma. Tells of cleaned mice have killed longer and tumor cells more effectively, resulting in researchers resulting in cancer growth.

“Our findings show that the researchers can be repeated in the paper,” researchers said in the paper to protect solid tumor functions in the target of signal roads.

In recent years, scientists have developed a treatment class that increases the recognition of cancers, known as immuning as immunity as immunity immunity. Thus, UM believes that the proteins can be used in conjunction with existing immunotherapy to maintain t cells in type of cancer-bashing. They believe that more wider, other organisms or their genes can become wiring to change our immune cells.

The team’s protein is still experimental, so it will conduct a lot of research to know that people are safe and effectively used. However, other herpesvirus cannot take a long time to contribute to cancer treatment. Several research teams have developed variable versions Herpes Simplex 1 virus (the main cause of cold wounds) to remove the tumors directly. Some of these treatments have already been tested in humans and have promised in early clinical trials so far.